| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/21/2010 | WO2010007046A2 Organic compounds |
| 01/21/2010 | WO2010007032A1 Piperidine based ureas as nk1 antagonists |
| 01/21/2010 | WO2010006962A1 Derivatives of triazines and uracils, their preparation and their application in human therapeutics |
| 01/21/2010 | WO2010006945A1 Substituted indolyl and indazolyl derivatives and uses thereof |
| 01/21/2010 | WO2010006944A1 Aminotetrahydroindazoloacetic acids |
| 01/21/2010 | WO2010006939A1 Aminotetrahydroindazoloacetic acids |
| 01/21/2010 | WO2010006938A1 Novel heterocyclyl compounds for treatment of cardiovascular disease |
| 01/21/2010 | WO2010006904A2 New crystalline forms of rabeprazole sodium |
| 01/21/2010 | WO2010006713A2 Heterocyclic compounds used as pesticides |
| 01/21/2010 | WO2010006438A1 Thiosemicarbazone inhibitor compounds and cancer treatment methods |
| 01/21/2010 | WO2009138219A3 Insecticidal compounds |
| 01/21/2010 | WO2009135651A8 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase cyp11b2 |
| 01/21/2010 | WO2009131493A3 5-hydroxy-4-aminomethyl-1-cyclohexane or (cycloheptyl)--3-alkoxycarbonyl indole derivatives, pharmaceutically acceptable antiviral salts thereof and a method for the production thereof |
| 01/21/2010 | WO2009112677A3 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 01/21/2010 | WO2008156092A8 Azolylmethylidenehydrazine derivative and use thereof |
| 01/21/2010 | WO2008130312A8 A new process for the manufacturing of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1h-indole-5-carbonitrile 701 |
| 01/21/2010 | US20100016606 Preparation of amorphous hydrous esomeprazole magnesium |
| 01/21/2010 | US20100016605 Process |
| 01/21/2010 | US20100016603 Production process of 2,3'-bipyridyl-6'-one |
| 01/21/2010 | US20100016596 Process for the purification of neuromuscular blocking agents |
| 01/21/2010 | US20100016593 Crystalline forms of palonosetron hydrochloride |
| 01/21/2010 | US20100016590 Nilotinib intermediates and preparation thereof |
| 01/21/2010 | US20100016589 Novel Anthranilic Acid Derivative as Potential Anticancer Agent and a Process for the Preparation Thereof |
| 01/21/2010 | US20100016587 Protein Kinase Targeted Therapeutics |
| 01/21/2010 | US20100016578 Macrocyclic serine protease inhibitors |
| 01/21/2010 | US20100016380 TNF-alpha production inhibitors |
| 01/21/2010 | US20100016375 1,5-diphenyl-3-pyridinylamino-1,5-dihydropyrrolidin-2-one as cb1 receptor modulator |
| 01/21/2010 | US20100016374 Compounds Which Inhibit the Glycine Transporter and Uses Thereof |
| 01/21/2010 | US20100016373 such as 1-methyl-1H-imidazole-4-carboxylic acid 4-(3-hydroxy-4-isobutyryl-2-trifluoromethyl-phenoxymethyl)-benzylamide; preferential modulatators of glutamate receptors, used as antidepressants and anxiolytic agents |
| 01/21/2010 | US20100016372 Benzimidazole Derivatives |
| 01/21/2010 | US20100016371 Indole Compounds |
| 01/21/2010 | US20100016370 Process for the preparation of esomeprazole magnesium in a stable form |
| 01/21/2010 | US20100016369 Aminotetrahydroindazoloacetic acids |
| 01/21/2010 | US20100016368 Aminotetrahydroindazoloacetic acids |
| 01/21/2010 | US20100016367 Bis-pyrinidium compounds |
| 01/21/2010 | US20100016365 Substituted 4-amino-piperidines |
| 01/21/2010 | US20100016361 Aryl carboxylic acid cyclohexyl amide derivatives |
| 01/21/2010 | US20100016360 Alpha7 nicotinic acetylcholine receptor inhibitors |
| 01/21/2010 | US20100016353 Benzoimidazole derivatives useful as antiproliferative agents |
| 01/21/2010 | US20100016343 Alpha7 nicotinic acetylcholine receptor inhibitors |
| 01/21/2010 | US20100016342 Solid forms comprising 3-(2,5-dimethyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, compositions comprising the same, and methods of using the same |
| 01/21/2010 | US20100016340 Pharmaceutical compounds |
| 01/21/2010 | US20100016337 Heteroaryl-substituted carboxamides and their use as pharmaceuticals |
| 01/21/2010 | US20100016331 Novel compounds |
| 01/21/2010 | US20100016327 Quinoline compounds |
| 01/21/2010 | US20100016320 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors |
| 01/21/2010 | US20100016319 Arylmethylene urea derivative and use thereof |
| 01/21/2010 | US20100016316 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 01/21/2010 | US20100016314 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv |
| 01/21/2010 | US20100016312 Substituted indolyl and indazolyl derivatives and uses thereof |
| 01/21/2010 | US20100016308 Tetrahydroindole Derivatives for Treatment of Alzheimer's Disease |
| 01/21/2010 | US20100016298 Theramutein modulators |
| 01/21/2010 | US20100016297 Alkyl-substituted 3' compounds having 5-ht6 receptor affinity |
| 01/21/2010 | US20100016291 Mtp inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives |
| 01/21/2010 | US20100016282 Novel heterocyclyl compounds |
| 01/21/2010 | US20100016277 Diazabicyclic central nervous system active agents |
| 01/21/2010 | US20100016272 Heteroarylacrylamides and their use as pharmaceuticals |
| 01/21/2010 | US20100016259 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 01/21/2010 | US20100015717 Mass Tags for Quantitive Analysis |
| 01/21/2010 | US20100015093 Methods and compositions of treating a flaviviridae family viral infection |
| 01/21/2010 | US20100015063 Benzodiazepine Derivatives and Pharmaceutical Compositions Containing Them |
| 01/21/2010 | CA2731196A1 Benzazepine derivatives and their use as hstamine h3 antagonists |
| 01/21/2010 | CA2731130A1 Pyridazine derivatives as smo inhibitors |
| 01/21/2010 | CA2731097A1 Organic compounds |
| 01/21/2010 | CA2730929A1 Pyridone and pyridazone analogues as gpr119 modulators |
| 01/21/2010 | CA2730890A1 Thiosemicarbazone inhibitor compounds and cancer treatment methods |
| 01/21/2010 | CA2730844A1 Heterocyclic compounds used as pesticides |
| 01/21/2010 | CA2730793A1 Azole compound |
| 01/21/2010 | CA2730397A1 Substituted indolyl and indazolyl derivatives and uses thereof |
| 01/21/2010 | CA2730390A1 Aminotetrahydroindazoloacetic acids |
| 01/21/2010 | CA2730281A1 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 01/21/2010 | CA2730056A1 Novel heterocyclyl compounds for treatment of cardiovascular disease |
| 01/21/2010 | CA2729990A1 New chemical compounds |
| 01/21/2010 | CA2729986A1 New chemical compounds |
| 01/21/2010 | CA2729606A1 Alpha7 nicotinic acetylcholine receptor inhibitors |
| 01/21/2010 | CA2728311A1 Aminotetrahydroindazoloacetic acids |
| 01/21/2010 | CA2728095A1 Pyrazole-containing tricyclic compounds as antagonists of an ep1 receptor |
| 01/21/2010 | CA2727174A1 Aryl gpr119 agonists and uses thereof |
| 01/20/2010 | EP2145885A1 Hydrazide compound and harmful arthropod-controlling agent containing the same |
| 01/20/2010 | EP2145884A1 Indoledione derivative |
| 01/20/2010 | EP2145622A1 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |
| 01/20/2010 | EP2144898A2 Heterocyclic hydrazide compound and pesticidal use of the same |
| 01/20/2010 | EP2144896A1 Novel crystalline bepotastine metal salt hydrate, method for preparing same, and pharmaceutical composition comprising same |
| 01/20/2010 | EP2144894A1 Oxime ester photoinitiators |
| 01/20/2010 | EP2144881A1 Isoquinolinone derivatives, processes for their preparation and their use in the treatment of chronic obstructive pulmonary disease ( copd ) and asthma |
| 01/20/2010 | EP2144879A2 Pyridonecarboxamides crop protection agents containing the same method for production and use thereof |
| 01/20/2010 | EP2144877A1 Novel pyridine derivatives, processes for preparing them, pharmaceutical compositions thereof |
| 01/20/2010 | EP1805141B1 Piperidines and related compounds for treatment of alzheimer's disease |
| 01/20/2010 | EP1663211B1 Aminotriazole compounds useful as inhibitors of protein kinases |
| 01/20/2010 | EP1648880B1 Therapeutic agents useful for treating pain |
| 01/20/2010 | CN101631785A Substituted dihydropyrazolones for treating cardiovascular and haematological diseases |
| 01/20/2010 | CN101631784A Bicyclic lactam factor VIIA inhibitors useful as anticoagulants |
| 01/20/2010 | CN101628912A Anti-tumor compound containing triazole heterocyclic structure and application thereof |
| 01/20/2010 | CN101628911A Antibiotic drug |
| 01/20/2010 | CN101628888A Inhibitors of cytosolic phospholipase A2 |
| 01/20/2010 | CN100582107C Solvent-free process for the preparation of diketopyrrolopyrrole derivatives |
| 01/20/2010 | CN100582095C Method for chiral inversion of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof |
| 01/19/2010 | US7649085 Saquinavir conjugates and antibodies useful in immunoassay |
| 01/19/2010 | US7649015 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing |
| 01/19/2010 | US7649011 Inhibitors of human tumor-expressed CCXCKR2 |